This article explains why a N-Assay for the coronavirus is

New Post Public Reply Private Reply Replies (1) Message Board
nmbr1stckpckr
428
This article explains why a N-Assay for the coronavirus is critically needed!

https://www.nbcnews.com/health/health-care/ma...g-n1156006

"Several versions of a test are in use in the U.S., including the one developed by the Centers for Disease Control and Prevention. The CDC has made its test available to qualified laboratories, but some private labs lack the equipment to run it, Birenbaum said."

This is likely in reference to the machines needed to do PCR. N-Assay would be cheap!

"In the past week, Quest and LabCorp — two of the country's biggest clinical testing providers — began rolling out their own commercial tests to doctors and medical providers. But results typically take three to four days from the time specimens are picked up, the companies said."

Three to four days?! Probably because they have to ship the sample to the lab with PCR machines and then get put queue to process along with all the other samples. I recall that PCR machines require a qualified technician to operate. N-Assay is a point of care test.

"The turnaround is usually far quicker for smaller private labs and academic labs, because the testing is conducted on site instead of shipped to a central facility. Several private labs said they would be able to produce results within four hours once they were cleared to begin testing.

Quick turnaround is critical to slowing the virus, as an infected person may expose others before getting results back."


Three to four hours if the equipment is available onsite. I wonder how this duration is impacted by volume of test requested. They would have to be able to scale up with the number of PCR machines, but keep in mind that these machines are $$$$$. I think time to result was measured in minutes for the N-Assay.

"So far, the FDA has received requests from 14 private labs for expedited authorization, and 10 of them have begun patient testing, according to a spokesperson for the FDA. Many more labs and diagnostic device companies haven't even gotten to the point of requesting authorization because they are still developing their tests and trying to meet the FDA's requirements, industry representatives and lab experts said.

"We are talking to them around the clock, and our door is open for any developers who want to have a test for use in the U.S.," FDA Commissioner Stephen Hahn said Saturday."


If well-funded labs are having this much difficulty with a receptive CDC, I wonder what chance our little Company has. At least there would be minimal development time since all the ingredients are available and its only a matter of configuring the N-Assay to detect antibodies of the coronavirus.

"The University of Vermont Medical Center hasn't developed a test in-house and doesn't have the equipment to run the CDC's test. So it is waiting for commercial manufacturers to develop a test that its lab can use, Wojewoda said. And getting the test isn't the end of the process. "When we get it into the lab, we need to make sure it works in our hands," she said, noting that the validation process could take another week to complete.

One of the diagnostic tests the FDA is reviewing is made by Thermo Fisher, a major testing manufacturer. It would cut processing time to four hours, said Ron O'Brien, a spokesman for the company. However, FDA approval could still take weeks, O'Brien said."


Public labs are under pressure waiting for the CDC to get their act together and are open to using tests developed by private companies. And even the test from Thermo Fisher cuts processing time to four hours -- PCR? And I wonder why he didn't use the words "provide results" instead of "cut processing time"? Makes me think additional time is needed for the result.

"We've had a lot of issues with payments not covering the cost of the tests," Birenbaum said. "For our labs, it's a big investment to gear up for this. We're going to need to know if it's at least going to cover costs."

A lot of the cost is the investment in the PCR machines! Reimbursements to the labs in the thousands? Remember that guy who paid $3,000.00 to get himself tested? The N-Assay would be in the hundreds!!

"An academic research institute in New Jersey spent weeks developing a test that it says will produce results within four hours. Hackensack Meridian Health said in a statement that the in-house test will drastically reduce its turnaround time, as it consults with the state Health Department and then sends results to a state lab, which can take one to two days."

That "four hours" again....

It's a no brainer!!! All we need is for the CDC to give us a shot, but it sounds like they are only considering fully developed kits , which requires money that the Company does not have. All its resources are tied up with the goal of commercial launch of N-Assay for a handful of bacteria mentioned in previous updates.

This situation makes me sick.

On the other hand, I listened to some expert on pandemics say that the coronavirus will eventually turn into another seasonal flu. I didn't know, but the flues that go around now were also pandemics when they first came about. The goal now is to make it so that not everyone gets sick all at once such that it overwhelms our healthcare system.
1

Nanologix Inc (NNLX) Stock Research Links

NNLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Debbie's Dream Foundation Launches 2026 Youth Art Contest

Updated Category News Views 5

Young Artists Called to Inspire a Cancer-Free World What's the first image that pops into your head when you think of a world free from cancer? That's the magic question on deck for this year's Youth Art Contest by Debbie's Dream Foundation. Imaginations are set to run wild as the competition opens its gates to artists under 18, calling for visions splashed across...

Continue Reading
Invictus Pharmacy Secures LegitScript Certification Status

Updated Category News Views 2

A New Chapter for Invictus Pharmacy In a world tangled up in red tape, Invictus Pharmacy somehow managed to cut a clear path by earning the LegitScript Healthcare Merchant Certification. Now, it seems like they've joined the ranks of the big players, including the likes of Amazon Pharmacy. It’s not just a shiny badge on their website, folks. It’s better access to...

Continue Reading
Kobold Press Explores Roleplaying as Literacy Tool

Updated Category News Views 5

Gaming Illuminates Pathways to Literacy and Community Trust me, when an indie game publisher like Kobold Press makes waves, it's worth paying attention. They've carved a niche in the roleplaying world by marrying traditional game elements with valuable educational tools. The thrill of the game goes beyond rolling dice; it's a ticket to improving literacy, arithmetic, and...

Continue Reading
GenAI Boosts Grades and Tech Savvy for Online Learners

Updated Category News Views 3

What's Really Driving GenAI Use in Online Education? Let's not beat around the bush—most folks think students turn to this newfangled generative AI mainly to smooth over academic hurdles or save time. But guess what? The University of Phoenix has gone and poked some holes in that assumption. Study Highlights Key Insights This solid piece of research from the...

Continue Reading
AI Agents Challenge Product Governance Models

Updated Category News Views 7

AI's Increasing Role: A Double-Edged Sword for Leaders Hey, the tech overlords remind us once again—the future doesn't wait for anyone to catch up before it bulldozes forward. Info-Tech Research Group has sounded the alarm on AI agents muscling their way into product decisions without any clear nod from the human corner office. Blurring Lines of Accountability The...

Continue Reading
Celebrate National Service Dog Month with Canine Companions

Updated Category News Views 5

A Month to Celebrate Unseen Heroes Take a pause. We're talking about National Service Dog Month. What in the world could be more endearing than a pack of puppies, those hopeful bundles of joy, destined to grow up and play pivotal roles in people's lives? Canine Companions is rolling out the red carpet for these future heroes, with a nine-day Puppy Cam event from September...

Continue Reading
Bascom's Strategic Play on a Dallas Apartment Deal

Updated Category News Views 8

Unpacking Bascom's Jasmine Acquisition In a market that's been more slippery than a greased pig, Bascom Group's move buying up Jasmine Apartments is capturing some eyes. Situated in North Dallas, this 370-unit complex ain't just another brick in the wall—it's Bascom's 42nd entry into Texas, reinforcing their knack for sniffing out deals others might tiptoe around,...

Continue Reading
IRS Views Challenge Tax-Engineered Healthcare Schemes

Updated Category News Views 4

Nonprofit Models Shine Amid IRS Scrutiny Out in Oxnard, California, there's a brewing storm in the healthcare sector. No, it's not a billing error or yet another scandal. We're talking about a seismic shift that could poke holes in those tax-engineered Section 105(b) programs, all thanks to some hard-hitting IRS memoranda. The Nonprofit–TPA Model: A Safer Bet? Enter...

Continue Reading
Chattanooga: A New Epicenter for Quantum Computing

Updated Category News Views 4

Quantum Leap: Chattanooga's Bold Move So Chattanooga’s making waves again, folks. EPB just unveiled its new big shot, the IonQ Forte Enterprise quantum computer. That's right, they’ve slapped a commercial quantum computer and a networking hub together, right here in this Tennessee city. Is this a tech haven or what? Not to mention, it’s the first in America. A New...

Continue Reading
Digital Wine Atlas Maps 4.3 Million Vineyards Globally

Updated Category News Views 4

Revolutionizing Viticulture with Data In today's wild world, climate change isn't just shifting weather patterns—it's upending the age-old map of wine-making regions. We've got a new player on the field: the World Winery Map. It's digital, massive, and it’s shaking things up for winemakers and grape enthusiasts alike. This platform covers a staggering 4.3 million...

Continue Reading

Top 5 Most Recently Viewed Articles

Projected Growth of Molecular Targeted Therapy Market to $246B

Updated Category News Views 139

Growth Forecast of the Molecular Targeted Therapy Market The Molecular Targeted Therapy Market is on a remarkable upward trajectory, with its valuation expected to more than double in the coming years. Initially valued at around $127 billion, projections indicate it will soar to an impressive $246 billion by the year 2034, marking a substantial increase fueled by various...

Continue Reading
Imperial Oil Limited: The Rising Star of the Energy Sector

Updated Category News Views 237

Imperial Oil Limited's Exceptional Performance in the Energy Sector Imperial Oil Limited (AMEX: IMO) has been making waves recently with an impressive 16% growth in its share price so far this year. In contrast, the broader oil and energy sector has only seen a slight decline of 0.3%. This stark difference raises an essential question for investors: should you invest in...

Continue Reading
Secure Your Business's Future with LegalZoom Trademark Services

Updated Category News Views 108

Protecting Your Brand in the Digital Age As competition in the digital landscape grows, small business owners find themselves facing challenges like never before. LegalZoom, a pioneer in online legal services, emphasizes the importance of trademark registration to help these entrepreneurs protect their intellectual property. In a world where artificial intelligence has...

Continue Reading
EVgo's Q4 Earnings Anticipation: Can Relief Rally Begin Soon?

Updated Category News Views 143

EVgo Faces Critical Earnings Report Amid Market Dynamics EVgo Inc (NASDAQ: EVGO) is gearing up to share its fourth-quarter earnings soon, and all eyes are on this electric vehicle charging company. Wall Street anticipates a loss of 9 cents per share, paired with projected revenues of approximately $69.10 million. The company’s earnings call is expected to take place...

Continue Reading
Join Crocs, Inc. Securities Fraud Lawsuit with Schall Firm

Updated Category News Views 178

Understanding the Crocs, Inc. Securities Fraud Class Action Investors in the footwear industry have a significant opportunity to take part in a class action lawsuit involving Crocs, Inc. This lawsuit, concerning alleged securities fraud, arises from various misleading statements made by the Company regarding its revenues and financial health. Investing in Crocs: A Closer...

Continue Reading